168 related articles for article (PubMed ID: 21258763)
1. Spinal cord injury and bladder dysfunction: new ideas about an old problem.
Cruz CD; Cruz F
ScientificWorldJournal; 2011 Jan; 11():214-34. PubMed ID: 21258763
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia.
Chen CY; Liao CH; Kuo HC
Spinal Cord; 2011 May; 49(5):659-64. PubMed ID: 21243000
[TBL] [Abstract][Full Text] [Related]
4. Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder.
Chen SF; Chang CH; Kuo HC
Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27249005
[TBL] [Abstract][Full Text] [Related]
5. Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats.
Coelho A; Oliveira R; Cruz F; Cruz CD
Exp Neurol; 2016 Nov; 285(Pt B):159-166. PubMed ID: 27235935
[TBL] [Abstract][Full Text] [Related]
6. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
Giannantoni A; Mearini E; Del Zingaro M; Porena M
Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanism Operating in Animal Models of Neurogenic Detrusor Overactivity: A Systematic Review Focusing on Bladder Dysfunction of Neurogenic Origin.
Ferreira A; Nascimento D; Cruz CD
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834694
[TBL] [Abstract][Full Text] [Related]
8. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Leitner L; Guggenbühl-Roy S; Knüpfer SC; Walter M; Schneider MP; Tornic J; Sammer U; Mehnert U; Kessler TM
Eur Urol; 2016 Sep; 70(3):522-8. PubMed ID: 27106070
[TBL] [Abstract][Full Text] [Related]
9. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
Rovner E; Dmochowski R; Chapple C; Thompson C; Lam W; Haag-Molkenteller C
Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824
[TBL] [Abstract][Full Text] [Related]
10. Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.
Chen G; Liao L
Int Urol Nephrol; 2011 Sep; 43(3):655-62. PubMed ID: 21110094
[TBL] [Abstract][Full Text] [Related]
11. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction.
Welk B; Hickling D; McKibbon M; Radomski S; Ethans K
Neurourol Urodyn; 2018 Nov; 37(8):2810-2817. PubMed ID: 30168626
[TBL] [Abstract][Full Text] [Related]
12. TASCI-transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomised, sham-controlled, double-blind clinical trial.
Birkhäuser V; Liechti MD; Anderson CE; Bachmann LM; Baumann S; Baumberger M; Birder LA; Botter SM; Büeler S; Cruz CD; David G; Freund P; Friedl S; Gross O; Hund-Georgiadis M; Husmann K; Jordan X; Koschorke M; Leitner L; Luca E; Mehnert U; Möhr S; Mohammadzada F; Monastyrskaya K; Pfender N; Pohl D; Sadri H; Sartori AM; Schubert M; Sprengel K; Stalder SA; Stoyanov J; Stress C; Tatu A; Tawadros C; van der Lely S; Wöllner J; Zubler V; Curt A; Pannek J; Brinkhof MWG; Kessler TM
BMJ Open; 2020 Aug; 10(8):e039164. PubMed ID: 32792454
[TBL] [Abstract][Full Text] [Related]
13. The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO).
Frias B; Santos J; Morgado M; Sousa MM; Gray SM; McCloskey KD; Allen S; Cruz F; Cruz CD
J Neurosci; 2015 Feb; 35(5):2146-60. PubMed ID: 25653370
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of trigonal BTX-A injections for children with neurological detrusor overactivity secondary to spinal cord injury.
Hui C
J Pediatr Surg; 2020 Dec; 55(12):2736-2739. PubMed ID: 32571538
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury.
Hamid R; Averbeck MA; Chiang H; Garcia A; Al Mousa RT; Oh SJ; Patel A; Plata M; Del Popolo G
World J Urol; 2018 Oct; 36(10):1517-1527. PubMed ID: 29752515
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic treatment of vesicoureteral reflux with non-simultaneous involuntary detrusor contraction in chronic spinal cord injury patients with neurogenic detrusor overactivity.
Vírseda MC; Salinas JC; Bolufer E; Esteban MF
Urol Int; 2014; 93(4):399-402. PubMed ID: 24642572
[TBL] [Abstract][Full Text] [Related]
17. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).
Cruz F; Nitti V
Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S26-31. PubMed ID: 25042140
[TBL] [Abstract][Full Text] [Related]
18. Urodynamic Differences between Complete and Incomplete Spinal Cord Injuries with Neurogenic Detrusor Overactivity.
García Fadrique G; Gallego D; Ordaz D; Climent L
Urol Int; 2020; 104(3-4):273-276. PubMed ID: 31461727
[TBL] [Abstract][Full Text] [Related]
19. Neurogenic detrusor overactivity: comparison between complete and incomplete spinal cord injury patients.
Moslavac S; Dzidic I; Kejla Z
Neurourol Urodyn; 2008; 27(6):504-6. PubMed ID: 18508334
[TBL] [Abstract][Full Text] [Related]
20. Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results.
Gobeaux N; Yates DR; Denys P; Even-Schneider A; Richard F; Chartier-Kastler E
Neurourol Urodyn; 2012 Jun; 31(5):672-6. PubMed ID: 22532256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]